Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

A systematic review and meta-analysis of stereotactic body radiation therapy for colorectal pulmonary metastases.

Cao C, Wang D, Tian DH, Wilson-Smith A, Huang J, Rimner A.

J Thorac Dis. 2019 Dec;11(12):5187-5198. doi: 10.21037/jtd.2019.12.12.

2.

Delivering safe and effective stereotactic body radiation therapy for patients with centrally located early stage non-small cell lung cancer.

Haseltine JM, Rimner A, Shepherd AF, Wu AJ, Gelblum DY, Shaverdian N, Gomez DR, Simone CB 2nd.

Chin Clin Oncol. 2020 Jan 15. pii: cco.2019.12.17. doi: 10.21037/cco.2019.12.17. [Epub ahead of print] No abstract available.

3.

VA-Radiation Oncology Quality Surveillance Program.

Hagan M, Kapoor R, Michalski J, Sandler H, Movsas B, Chetty I, Lally B, Rengan R, Robinson C, Rimner A, Simone C, Timmerman R, Zelefsky M, DeMarco J, Hamstra D, Lawton C, Potters L, Valicenti R, Mutic S, Bosch W, Abraham C, Caruthers D, Brame R, Palta JR, Sleeman W, Nalluri J.

Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):639-647. doi: 10.1016/j.ijrobp.2019.08.064. Epub 2020 Jan 23.

PMID:
31983560
4.

Technical Note: 3D localization of lung tumors on cone beam CT projections via a convolutional recurrent neural network.

Wang C, Hunt M, Zhang L, Rimner A, Yorke E, Lovelock M, Li X, Li T, Mageras G, Zhang P.

Med Phys. 2020 Jan 28. doi: 10.1002/mp.14007. [Epub ahead of print]

PMID:
31899807
5.

Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer.

Shaverdian N, Offin MD, Rimner A, Shepherd AF, Wu AJ, Rudin CM, Hellmann MD, Chaft JE, Gomez DR.

Radiother Oncol. 2019 Nov 28;144:101-104. doi: 10.1016/j.radonc.2019.11.015. [Epub ahead of print]

PMID:
31786421
6.

The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors.

Ruffini E, Fang W, Guerrera F, Huang J, Okumura M, Kim DK, Girard N, Billè A, Boubia S, Cangir AK, Detterbeck F, Falkson C, Filosso PL, Giaccone G, Kondo K, Infante M, Lucchi M, Marino M, Marom EM, Nicholson AG, Rimner A, Rami-Porta R, Asamura H; Staging and Prognostic Factors Committee; Staging and Prognostic Factors-Thymic Domain Subcommittee; Staging and Prognostic Factors Subcommittees; Members of the Advisory Boards.

J Thorac Oncol. 2020 Mar;15(3):436-447. doi: 10.1016/j.jtho.2019.11.013. Epub 2019 Nov 27.

PMID:
31783179
7.

Response to Letter to Editor from Fodor et al., "The 'Radical' Palliation That Increases Survival in Malignant Pleural Mesothelioma".

Gomez DR, Rimner A.

J Thorac Oncol. 2019 Dec;14(12):e284-e285. doi: 10.1016/j.jtho.2019.09.199. No abstract available.

PMID:
31757385
8.

LDeform: Longitudinal deformation analysis for adaptive radiotherapy of lung cancer.

Nadeem S, Zhang P, Rimner A, Sonke JJ, Deasy JO, Tannenbaum A.

Med Phys. 2020 Jan;47(1):132-141. doi: 10.1002/mp.13907. Epub 2019 Nov 26.

PMID:
31693764
9.

Dose to the cardio-pulmonary system and treatment-induced electrocardiogram abnormalities in locally advanced non-small cell lung cancer.

Hotca A, Thor M, Deasy JO, Rimner A.

Clin Transl Radiat Oncol. 2019 Sep 21;19:96-102. doi: 10.1016/j.ctro.2019.09.003. eCollection 2019 Nov.

10.

Are unsatisfactory outcomes after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer due to treatment-related immunosuppression?

Thor M, Montovano M, Hotca A, Luo L, Jackson A, Wu AJ, Deasy JO, Rimner A.

Radiother Oncol. 2019 Oct 12. pii: S0167-8140(19)33009-9. doi: 10.1016/j.radonc.2019.07.016. [Epub ahead of print]

PMID:
31615633
11.

Long-term, disease-specific outcomes of thymic malignancies presenting with de novo pleural metastasis.

Choe G, Ghanie A, Riely G, Rimner A, Park BJ, Bains MS, Rusch VW, Adusumilli PS, Downey RJ, Jones DR, Huang J.

J Thorac Cardiovasc Surg. 2019 Sep 13. pii: S0022-5223(19)31772-6. doi: 10.1016/j.jtcvs.2019.08.037. [Epub ahead of print]

PMID:
31610957
12.

Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.

Iocolano M, Wild AT, Hannum M, Zhang Z, Simone CB 2nd, Gelblum D, Wu AJ, Rimner A, Shepherd AF.

Acta Oncol. 2020 Feb;59(2):164-170. doi: 10.1080/0284186X.2019.1675907. Epub 2019 Oct 12.

PMID:
31608751
13.

Dual-input tracer kinetic modeling of dynamic contrast-enhanced MRI in thoracic malignancies.

Lee SH, Rimner A, Deasy JO, Hunt MA, Tyagi N.

J Appl Clin Med Phys. 2019 Nov;20(11):169-188. doi: 10.1002/acm2.12740. Epub 2019 Oct 11.

14.

Clinical evaluation of 4D MRI in the delineation of gross and internal tumor volumes in comparison with 4DCT.

Zhang J, Srivastava S, Wang C, Beckham T, Johnson C, Dutta P, Shepherd A, Mechalakos J, Hunt M, Wu A, Rimner A, Li G.

J Appl Clin Med Phys. 2019 Sep;20(9):51-60. doi: 10.1002/acm2.12699.

15.

Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.

Gill RR, Tsao AS, Kindler HL, Richards WG, Armato SG 3rd, Francis RJ, Gomez DR, Dahlberg S, Rimner A, Simone CB 2nd, de Perrot M, Blumenthal G, Adjei AA, Bueno R, Harpole DH Jr, Hesdorffer M, Hirsch FR, Pass HI, Yorke E, Rosenzweig K, Burt B, Fennell DA, Lindwasser W, Malik S, Peikert T, Mansfield AS, Salgia R, Yang H, Rusch VW, Nowak AK.

J Thorac Oncol. 2019 Oct;14(10):1718-1731. doi: 10.1016/j.jtho.2019.08.012. Epub 2019 Aug 27.

PMID:
31470129
16.

Toward predicting the evolution of lung tumors during radiotherapy observed on a longitudinal MR imaging study via a deep learning algorithm.

Wang C, Rimner A, Hu YC, Tyagi N, Jiang J, Yorke E, Riyahi S, Mageras G, Deasy JO, Zhang P.

Med Phys. 2019 Oct;46(10):4699-4707. doi: 10.1002/mp.13765. Epub 2019 Sep 6.

PMID:
31410855
17.

Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.

Zauderer MG, Jayakumaran G, DuBoff M, Zhang L, Francis JH, Abramson DH, Cercek A, Nash GM, Shoushtari A, Chapman P, D'Angelo S, Arnold AG, Siegel B, Fleischut MH, Ni A, Rimner A, Rusch VW, Adusumilli PS, Travis W, Sauter JL, Zehir A, Mandelker D, Ladanyi M, Robson M.

J Thorac Oncol. 2019 Nov;14(11):1989-1994. doi: 10.1016/j.jtho.2019.07.002. Epub 2019 Jul 16.

PMID:
31323388
18.

Cross-modality (CT-MRI) prior augmented deep learning for robust lung tumor segmentation from small MR datasets.

Jiang J, Hu YC, Tyagi N, Zhang P, Rimner A, Deasy JO, Veeraraghavan H.

Med Phys. 2019 Oct;46(10):4392-4404. doi: 10.1002/mp.13695. Epub 2019 Aug 20.

PMID:
31274206
19.

Spatial signature of dose patterns associated with acute radiation-induced lung damage in lung cancer patients treated with stereotactic body radiation therapy.

Palma G, Monti S, Thor M, Rimner A, Deasy JO, Cella L.

Phys Med Biol. 2019 Aug 7;64(15):155006. doi: 10.1088/1361-6560/ab2e16.

PMID:
31261141
20.

Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models.

Thor M, Deasy J, Iyer A, Bendau E, Fontanella A, Apte A, Yorke E, Rimner A, Jackson A.

Radiother Oncol. 2019 Sep;138:45-51. doi: 10.1016/j.radonc.2019.05.011. Epub 2019 May 27.

PMID:
31146070
21.

The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

Gomez DR, Rimner A, Simone CB 2nd, Cho BCJ, de Perrot M, Adjei AA, Bueno R, Gill RR, Harpole DH Jr, Hesdorffer M, Hirsch FR, Jackson AA, Pass HI, Rice DC, Rusch VW, Tsao AS, Yorke E, Rosenzweig K.

J Thorac Oncol. 2019 Jul;14(7):1172-1183. doi: 10.1016/j.jtho.2019.03.030. Epub 2019 May 22. Review.

PMID:
31125736
22.

BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy.

Smith EL, Mailankody S, Staehr M, Wang X, Senechal B, Purdon TJ, Daniyan AF, Geyer MB, Goldberg AD, Mead E, Santomasso BD, Landa J, Rimner A, Riviere I, Landgren O, Brentjens RJ.

Cancer Immunol Res. 2019 Jul;7(7):1047-1053. doi: 10.1158/2326-6066.CIR-18-0551. Epub 2019 May 21.

PMID:
31113804
23.

The role of radiation treatment in pleural mesothelioma: Highlights of the 14th International Conference of the International mesothelioma interest group.

MacRae RM, Ashton M, Lauk O, Wilson W, O'Rourke N, Simone CB 2nd, Rimner A.

Lung Cancer. 2019 Jun;132:24-27. doi: 10.1016/j.lungcan.2019.03.023. Epub 2019 Mar 31. Review.

PMID:
31097089
24.

Enhancement of Long-Term External-Internal Correlation by Phase-Shift Detection and Correction Based on Concurrent External Bellows and Internal Navigator Signals.

Milewski AR, Olek D, Deasy JO, Rimner A, Li G.

Adv Radiat Oncol. 2019 Mar 1;4(2):377-389. doi: 10.1016/j.adro.2019.02.001. eCollection 2019 Apr-Jun.

25.

Analysis of Toxic Effects With Antiangiogenic Agents Plus Stereotactic Body Radiation in Ultracentral Lung Tumors.

Wang C, Rimner A, Gelblum DY, Flynn J, Jackson A, Yorke E, Wu AJ.

JAMA Oncol. 2019 May 1;5(5):737-739. doi: 10.1001/jamaoncol.2019.0205. No abstract available.

PMID:
30946430
26.

Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.

Marciscano AE, Haimovitz-Friedman A, Lee P, Tran PT, Tomé WA, Guha C, Spring Kong FM, Sahgal A, El Naqa I, Rimner A, Marks LB, Formenti SC, DeWeese TL.

Int J Radiat Oncol Biol Phys. 2019 Mar 2. pii: S0360-3016(19)30290-1. doi: 10.1016/j.ijrobp.2019.02.046. [Epub ahead of print] No abstract available.

PMID:
30836168
27.

Segmenting lung tumors on longitudinal imaging studies via a patient-specific adaptive convolutional neural network.

Wang C, Tyagi N, Rimner A, Hu YC, Veeraraghavan H, Li G, Hunt M, Mageras G, Zhang P.

Radiother Oncol. 2019 Feb;131:101-107. doi: 10.1016/j.radonc.2018.10.037. Epub 2018 Dec 31.

28.

Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy.

Halpenny D, Raj M, Rimner A, Zheng J, Capanu M, Ginsberg MS.

Eur Radiol. 2019 Jul;29(7):3696-3704. doi: 10.1007/s00330-018-5937-6. Epub 2019 Jan 28.

PMID:
30689034
29.

Outcomes of Stage III NSCLC with occult primary vs. known primary lesions.

Romesser PB, Bardash Y, Buonocore D, Chaft JE, Huang J, Jones DR, Rimner A, Wu AJ.

Lung Cancer. 2019 Jan;127:34-36. doi: 10.1016/j.lungcan.2018.11.019. Epub 2018 Nov 17.

30.

Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?

Kong FS, Moiseenko V, Zhao J, Milano MT, Li L, Rimner A, Das S, Li XA, Miften M, Liao Z, Martel M, Bentzen SM, Jackson A, Grimm J, Marks LB, Yorke E.

Int J Radiat Oncol Biol Phys. 2018 Nov 26. pii: S0360-3016(18)34014-8. doi: 10.1016/j.ijrobp.2018.11.028. [Epub ahead of print]

PMID:
30496880
31.

A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers.

Sabari JK, Offin M, Stephens D, Ni A, Lee A, Pavlakis N, Clarke S, Diakos CI, Datta S, Tandon N, Martinez A, Myers ML, Makhnin A, Leger Y, Yu HA, Paik PK, Chaft JE, Kris MG, Jeon JO, Borsu LA, Ladanyi M, Arcila ME, Hernandez J, Henderson S, Shaffer T, Garg K, DiPasquo D, Raymond CK, Lim LP, Li M, Hellmann MD, Drilon A, Riely GJ, Rusch VW, Jones DR, Rimner A, Rudin CM, Isbell JM, Li BT.

J Natl Cancer Inst. 2019 Jun 1;111(6):575-583. doi: 10.1093/jnci/djy156.

32.

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.

Cao C, Wang D, Chung C, Tian D, Rimner A, Huang J, Jones DR.

J Thorac Cardiovasc Surg. 2019 Jan;157(1):362-373.e8. doi: 10.1016/j.jtcvs.2018.08.075. Epub 2018 Sep 15.

33.

Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.

Bodo S, Campagne C, Thin TH, Higginson DS, Vargas HA, Hua G, Fuller JD, Ackerstaff E, Russell J, Zhang Z, Klingler S, Cho H, Kaag MG, Mazaheri Y, Rimner A, Manova-Todorova K, Epel B, Zatcky J, Cleary CR, Rao SS, Yamada Y, Zelefsky MJ, Halpern HJ, Koutcher JA, Cordon-Cardo C, Greco C, Haimovitz-Friedman A, Sala E, Powell SN, Kolesnick R, Fuks Z.

J Clin Invest. 2019 Feb 1;129(2):786-801. doi: 10.1172/JCI97631. Epub 2019 Jan 14.

34.

Diffusion-weighted MRI of the lung at 3T evaluated using echo-planar-based and single-shot turbo spin-echo-based acquisition techniques for radiotherapy applications.

Tyagi N, Cloutier M, Zakian K, Deasy JO, Hunt M, Rimner A.

J Appl Clin Med Phys. 2019 Jan;20(1):284-292. doi: 10.1002/acm2.12493. Epub 2018 Nov 12.

35.

Design and validation of a MV/kV imaging-based markerless tracking system for assessing real-time lung tumor motion.

Zhang P, Hunt M, Telles AB, Pham H, Lovelock M, Yorke E, Li G, Happersett L, Rimner A, Mageras G.

Med Phys. 2018 Dec;45(12):5555-5563. doi: 10.1002/mp.13259. Epub 2018 Nov 13.

36.

Tumor-aware, Adversarial Domain Adaptation from CT to MRI for Lung Cancer Segmentation.

Jiang J, Hu YC, Tyagi N, Zhang P, Rimner A, Mageras GS, Deasy JO, Veeraraghavan H.

Med Image Comput Comput Assist Interv. 2018 Sep;11071:777-785. doi: 10.1007/978-3-030-00934-2_86.

37.

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, Harpole DH Jr, Hassan R, Hesdorffer M, Hirsch FR, Hmeljak J, Kindler HL, Korn EL, Liu G, Mansfield AS, Nowak AK, Pass HI, Peikert T, Rimner A, Robinson BWS, Rosenzweig KE, Rusch VW, Salgia R, Sepesi B, Simone CB 2nd, Sridhara R, Szlosarek P, Taioli E, Tsao MS, Yang H, Zauderer MG, Malik SM.

J Thorac Oncol. 2018 Nov;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036. Epub 2018 Sep 25.

38.

The expanding role of radiation therapy for thymic malignancies.

Willmann J, Rimner A.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2555-S2564. doi: 10.21037/jtd.2018.01.154. Review.

39.

Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition.

von Reibnitz D, Chaft JE, Wu AJ, Samstein R, Hellmann MD, Plodkowski AJ, Zhang Z, Shi W, Dick-Godfrey R, Panchoo KH, Barker CA, Rimner A.

Adv Radiat Oncol. 2018 May 9;3(3):391-398. doi: 10.1016/j.adro.2018.05.001. eCollection 2018 Jul-Sep.

40.

Evaluation of automatic contour propagation in T2-weighted 4DMRI for normal-tissue motion assessment using internal organ-at-risk volume (IRV).

Zhang J, Markova S, Garcia A, Huang K, Nie X, Choi W, Lu W, Wu A, Rimner A, Li G.

J Appl Clin Med Phys. 2018 Sep;19(5):598-608. doi: 10.1002/acm2.12431. Epub 2018 Aug 15.

41.

Validating a Predictive Atlas of Tumor Shrinkage for Adaptive Radiotherapy of Locally Advanced Lung Cancer.

Zhang P, Yorke E, Mageras G, Rimner A, Sonke JJ, Deasy JO.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):978-986. doi: 10.1016/j.ijrobp.2018.05.056. Epub 2018 Jun 2.

42.

Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).

von Reibnitz D, Shaikh F, Wu AJ, Treharne GC, Dick-Godfrey R, Foster A, Woo KM, Shi W, Zhang Z, Din SU, Gelblum DY, Yorke ED, Rosenzweig KE, Rimner A.

Acta Oncol. 2018 Nov;57(11):1567-1573. doi: 10.1080/0284186X.2018.1481292. Epub 2018 Jun 6.

43.

Stereotactic Body Radiation Therapy: Focusing on the Short Game.

Cao C, Huang J, Rimner A, Wang D, Chung C, Jones DR.

J Clin Oncol. 2018 Aug 10;36(23):2455-2456. doi: 10.1200/JCO.2018.78.2268. Epub 2018 Jun 4. No abstract available.

PMID:
29863976
44.

Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.

Brandt WS, Yan W, Leeman JE, Tan KS, Park BJ, Adusumilli PS, Bott MJ, Molena D, Isbell J, Chaft J, Rimner A, Jones DR.

Ann Thorac Surg. 2018 Sep;106(3):848-855. doi: 10.1016/j.athoracsur.2018.04.064. Epub 2018 May 26.

45.

Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.

Lee SH, Rimner A, Gelb E, Deasy JO, Hunt MA, Humm JL, Tyagi N.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):718-726. doi: 10.1016/j.ijrobp.2018.02.031. Epub 2018 Mar 2.

46.

PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT).

Lockney NA, Yang TJ, Barron D, Gelb E, Gelblum DY, Yorke E, Shi W, Zhang Z, Rimner A, Wu AJ.

Clin Transl Radiat Oncol. 2017 Dec;7:91-93. doi: 10.1016/j.ctro.2017.11.002. Epub 2017 Nov 4.

47.

Radiomics analysis of pulmonary nodules in low-dose CT for early detection of lung cancer.

Choi W, Oh JH, Riyahi S, Liu CJ, Jiang F, Chen W, White C, Rimner A, Mechalakos JG, Deasy JO, Lu W.

Med Phys. 2018 Apr;45(4):1537-1549. doi: 10.1002/mp.12820. Epub 2018 Mar 12.

48.

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

Kindler HL, Ismaila N, Armato SG 3rd, Bueno R, Hesdorffer M, Jahan T, Jones CM, Miettinen M, Pass H, Rimner A, Rusch V, Sterman D, Thomas A, Hassan R.

J Clin Oncol. 2018 May 1;36(13):1343-1373. doi: 10.1200/JCO.2017.76.6394. Epub 2018 Jan 18.

PMID:
29346042
49.

Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers.

Li BT, Stephens D, Chaft JE, Rudin CM, Jones DR, Rusch VW, Rimner A, Isbell JM.

Ann Transl Med. 2017 Dec;5(23):479. doi: 10.21037/atm.2017.09.02.

50.

The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.

Moghanaki D, Simone CB 2nd, Rimner A, Karas TZ, Donington J, Shirvani SM, Daly M, Videtic GM, Movsas B; ASTRO Evidence-Based Guideline Committee for Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Non–Small Cell Lung Cancer.

J Thorac Cardiovasc Surg. 2018 Jan;155(1):429-431. doi: 10.1016/j.jtcvs.2017.09.001. No abstract available.

Supplemental Content

Loading ...
Support Center